About

Formed in 2001, the School united biomedical research on the Clayton campus and is now one of the largest biomedical precincts in Australia. 

At a cost of over $110 million, two research buildings were built in 2008/09.  The buildings increased the size of the school and provide scientists with the latest facilities and equipment to expand their research programs.   

The laboratories accommodate over 500 scientists in over 17,000 square metres of space.

 In 2008 the School generated a research income of over $42.1 million.

Research

The School has over 700 research staff and over 270 PhD students.

In 2008 the School published a total of 416 papers:

29 were published in high impact journals including:  4 in Nature, 7 in Blood, 3 in Immunity, 1 in The Lancet, 4 in Hepatology, 2 in Journal of Experimental Medicine, 1 in Cell, 1 in Cancer Cell, 2 in Journal of Clinical Investigation, 1 in Current Biology, 1 in Developmental Cell.

Researchers have a variety of biomedical backgrounds and engage in cross discipline collaborations in areas including:

• Cancer
• Cardiovascular Disease
• Developmental Biology
• Fetal and Baby Health
• Infectious Diseases
• Medical Imaging and Radiation Sciences
• Neuroscience
• Obesity
• Pharmacology and Drug Design
• Stem Cells and Immunology
• Structural Biology.

Teaching

Researchers teach in a number of courses including Science, Biomedical Science, Behavioural Neuroscience, Medicine/Surgery, Nutrition and Dietetics, and Radiography and Medical Imaging. 

In 2008, the School taught 2180 undergraduate students and supervised 106 students who were undertaking the honours program in Science and Biomedical Science. 

Commercialisation

Encourages collaboration between researchers and investors to accelerate the technology discovery process, and produce commercialised outcomes important in addressing the needs of society.

Governance

Contact information of key members of the School of Biomedical Science.